Airborne influenza virus infection of mice can be prevented by gaseous chlorine dioxide (ClO 2 ). This study demonstrated that ClO 2 abolished the function of the haemagglutinin (HA) of influenza A virus (H1N1) in a concentration-, time-and temperature-dependent manner. The IC 50 during a 2 min reaction with ClO 2 at 25 6C was 13.7 mM, and the half-life time of HA with 100 mM ClO 2 at 25 6C was 19.5 s. Peptides generated from a tryptic digest of ClO 2 -treated virus were analysed by mass spectrometry. An HA fragment, 150 NLLWLTGK 157 was identified in which the tryptophan residue (W153) was 32 mass units greater than expected. The W153 residue of this peptide, which is derived from the central region of the receptor-binding site of HA, is highly conserved. It was shown that W153 was oxidized to N-formylkynurenine in ClO 2 -treated virus. It was concluded that the inactivation of influenza virus by ClO 2 is caused by oxidation of W153 in HA, thereby abolishing its receptor-binding ability.
INTRODUCTION
Influenza virus is an enveloped, negative-sense ssRNA virus with three transmembrane proteins, two of which are known as spike proteins, the haemagglutinin (HA) (Gamblin & Skehel, 2010; Skehel & Wiley, 2000) and neuraminidase (NA) (Xie et al., 2011) . The functions of HA are indispensable for the early establishment of infection in a target cell (Skehel & Wiley, 2000) . An HA receptor on the target cell binds to a receptor-binding site of HA. The site is a shallow groove made up of three elements, the 190 helix (an a-helix of residues [188] [189] [190] , the 130 loop (residues 134-138) and the 220 loop (residues 221-228) (Yang et al., 2007) . Conserved amino acid residues are present in the receptor-binding site, including Y98, S136, W153, H183, E190 and Y195 (Gamblin & Skehel, 2010; Stevens et al., 2004 Stevens et al., , 2006 . Among these conserved residues, W153 is located at the bottom of the binding site just below the acetamide moiety of the sialic acid (Nacetylneuraminic acid) residue of the receptor (Lin et al., 2009) .
Chlorine dioxide (ClO 2 ) is a relatively stable free radical. ClO 2 can inactivate various bacteria (Morino et al., 2011) , fungi (Morino et al., 2007) and viruses (Morino et al., 2009; Sanekata et al., 2010) . Ogata & Shibata (2008) recently demonstrated that low-concentration (0.03 p.p.m., v/v) ClO 2 gas reduced the mortality of mice exposed to aerosols of influenza A virus (H1N1), whilst Akamatsu et al. (2012) recently reported a 6-month continuous inhalation experiment using rats in which they showed that a 0.05 p.p.m. level of ClO 2 had no adverse effect. The effectiveness (Ogata & Shibata, 2008 ) of low-concentration ClO 2 gas indicates that this might be useful in preventing the transmission of influenza virus (Ogata & Shibata, 2009) . Although Ogata & Shibata (2008) showed that ClO 2 inactivated influenza virus, the molecular details of this inactivation mechanism were unclear. The results presented in this paper clearly demonstrate that inactivation of influenza virus by ClO 2 is due to oxidation and elimination of the function of the HA molecule.
RESULTS

Inhibition of haemagglutination by ClO 2
The ability of influenza virus particles to agglutinate chicken erythrocytes decreased when virus particles were treated with ClO 2 (Fig. 1a) with an IC 50 of 13.7 mM at 25 u C for 2 min and a half-life time for HA of 19.5 s at 25 uC with 100 mM ClO 2 (Fig. 1b) . This inactivation process was temperature dependent (Fig. 1c) , suggesting that the basis of the inhibition involved a chemical reaction. The activation energy of this inactivation process was determined by an Arrhenius plot (Fig. 1d) . From the fitted line y521970x+ 9.31 (r 2 50.93), the activation energy was found to be 16.4 kJ?mol 21 ?K
21
. Erythrocytes pre-treated with bacterial NA did not show agglutination (Fig. 1a) , indicating that the agglutination occurred via sialic acid residues in the glycoproteins of the erythrocytes.
Inhibition of receptor binding of HA by ClO 2
The ClO 2 -mediated inactivation of the ability of HA to bind its specific receptor was examined by direct binding of sialyl-a(2,6)-lactose-N-acetylated p-phenylenediaminederivatized human serum albumin conjugate (hereafter referred to as sialyl-albumin conjugate) to a microtitre plate pre-coated with HA. The ability of the conjugate to bind HA on the plate decreased markedly when HA was treated with ClO 2 (Fig. S1 , available in JGV Online). Taken together, these results suggested that ClO 2 abolishes the ability of HA to bind to its specific receptor.
Modification of HA by ClO 2 as revealed by mass spectrometry (MS)
The precise nature of the ClO 2 -induced modification of HA was investigated next. A tryptic digest of ClO 2 -treated virus particles was performed, and the resulting peptides were separated by HPLC and the fractions subjected to matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) MS. A fraction with a retention time of 25.0225.5 min (Fig. S2, fraction 45) showed a mass-tocharge ratio (m/z) value of 976.55 (Fig. 2a) , except that W153 was 32 mass units larger than expected (Fig. 2b) . This residue was tentatively assigned as N-formylkynurenine (FK) (Fig. 2a, inset ) based on previous reports (Ogata, 2007; Stewart et al., 2008) . The other MS peaks of the HPLC fractions are shown in Table S1 . 
Modification of synthetic peptide with ClO 2
A synthetic peptide of sequence NLLWLTGK treated with ClO 2 showed a novel peak with a retention time of 26.3 min, hereafter referred to as the 'ClO 2 -modified peptide' (data not shown). As a control, another peptide, NLLGLTGK, with a substitution of G for W (bold), was also treated with ClO 2 . This G-substituted peptide did not show any detectable change in mass after ClO 2 treatment (data not shown). These results suggested that the ClO 2 -induced modification was caused by the presence of a tryptophan residue in peptide NLLWLTGK. To further verify this interpretation, the absorbance and fluorescence emission spectra of the ClO 2 -modified peptide were compared with those of the original NLLWLTGK peptide. The absorbance and fluorescence spectral changes of the ClO 2 -modified peptide indicated that its tryptophan residue was covalently modified (data not shown).
MS analysis of the ClO 2 -modified peptide
The MALDI-TOF MS peak of the ClO 2 -modified peptide (m/z5976.79) (Fig. S3a ) was almost identical to the peak liberated after tryptic digestion from the ClO 2 -treated virus particles (Fig. 2a) . The spectrum obtained by MS/MS using the m/z5976.79 peak as a precursor ion also gave almost identical peaks (Fig. S3b ) to those generated from the HA fragment released from the ClO 2 -treated virus particles after trypsin digestion (Fig. 2b) . Moreover, the amino acid composition of the ClO 2 -modified peptide showed no tryptophan, although kynurenine was detected (data not shown 
DISCUSSION
ClO 2 reacts non-specifically with tryptophan and tyrosine residues in proteins (Napolitano et al., 2005; Ogata, 2007; Stewart et al., 2008) . However, it should be noted that ClO 2 does not necessarily react with all of the tryptophan and tyrosine residues in a specific protein (Ogata, 2007) . The different reactivity of ClO 2 against amino acid residues in any given protein might depend on whether these residues are easily accessible to ClO 2 or not. This study demonstrated that ClO 2 reacts with W153 preferentially, if not specifically, in HA (Fig. 2) . W153 is located on the surface of HA (Fig. 3a) and is presumably easily accessible to ClO 2 . It is also possible that the geometry of W153 in HA facilitates the reaction with ClO 2 . The binding ability of HA to its specific receptor on a target cell is crucial for establishing infection (Skehel & Wiley, 2000) . Because W153 in HA is highly conserved in almost all subtypes of influenza virus (Knossow & Skehel, 2006; Martín et al., 1998) , it is believed to play a crucially important role in the function of HA (Meisner et al., 2008) . As shown in Fig. 3(a, b) , W153 is located at the bottom of the receptor-binding site just below the sialic acid residue of the receptor (Lin et al., 2009) . In fact, the acetamide moiety (Fig. 3b) of the sialic acid is in van der Waals contact with the indole ring of W153 (Lin et al., 2009; Martín et al., 1998) . It is speculated that W153 together with Y195, which makes a hydrogen bond with the pyrrole nitrogen of W153, provides an optimal geometric structure that allows stable binding of the sialic acid residue of the receptor to HA. This proposed interaction explains why oxidation of W153 by ClO 2 is likely to abolish the function of HA (Fig. 1) .
It was shown previously by isotopic labelling experiments that ClO 2 oxidizes tryptophan to FK by transferring two atoms of oxygen from ClO 2 (Ogata, 2007) . In this reaction, the pyrrole ring of tryptophan is split, and the benzene ring of W153 will shift as shown in Fig. 3(c, lower arrow) . In addition, because the N-formyl bond in FK is a freely rotatable s bond, the oxygen atom of the formyl group may rotate upwards (in the direction of the sialic acid residue; Fig. 3c , upper arrow) to accommodate the bulky CO moiety.
These possible conformational changes in the binding site of HA are likely to perturb its interaction with the sialic acid residue. Additionally, such a conformational change in the receptor-binding site of HA would no longer enable formation of the necessary hydrogen bonds involving Y95, Y195, E190 and Q226 (Fig. 3a, dotted lines) to hold the sialic acid residue in place (Sauter et al., 1992 ClO 2 was prepared using NaClO 2 and HCl as described previously (Ogata, 2007) . The sialyl-albumin conjugate was obtained from IsoSep AB (Kallin et al., 1986) . This conjugate has 15 moles of the oligosaccharide moiety per mole of the protein. Trypsin was obtained from Promega. All other reagents were analytical grade and were obtained from Nacalai Tesque. Influenza virus particles were prepared in embryonated chicken eggs based on the method described by Herrmann (1978) . Approximately 3.5 mg virus protein in 1 ml was obtained from 100 eggs using this method.
Treatment of virus particles and HA with ClO 2 . Unless otherwise specified, the standard reaction for the treatment of virus particles or HA protein with ClO 2 was carried out in a 1 ml reaction mixture containing 10 mM sodium phosphate buffer (pH 7.0), 130 mM NaCl, 300 mM ClO 2 and virus particles (100 mg protein ml 21 ) or HA protein (100 mg ml
21
). The reaction was started by the addition of ClO 2 and was continued at 25 uC for 2 min. The reaction was terminated by the addition of a twofold molar excess of Na 2 S 2 O 3 (Ogata, 2007) . For a control experiment without ClO 2 treatment, ClO 2 that had been premixed with a twofold molar excess of Na 2 S 2 O 3 was added to the reaction mixture. For the reaction with virus particles, the reaction mixture was next heated at 100 uC for 3 min, followed by the addition of 38 ml trypsin solution (1 mg ml 21 ). The mixture was incubated at 37 uC for 5 h and then centrifuged at 20 000 g at 4 uC for 1 h. The supernatant was recovered and a 100 ml aliquot was subjected to HPLC.
Haemagglutination assay. A round-bottomed, 96-well polystyrene microtitre plate (Biotec) was used to measure the haemagglutination ability of virus particles. Virus particles that had been treated or not with ClO 2 were suspended in PBS. The virus particles were then diluted by twofold serial dilutions and placed in each well of the plate (50 ml per well). Fresh chicken erythrocytes, treated or not with Clostridium perfringens NA (0.39 U ml
, 37 uC for 10 min in PBS), were suspended in PBS at a concentration of 4610 7 cells ml 21 and then added to each well (50 ml per well). The plate was kept at 4 uC for 1 h. Agglutination of erythrocytes was observed by eye: a sheet of erythrocytes was formed on the bottom of the well if agglutination occurred; otherwise the erythrocytes formed a red 'spot' on the bottom in the centre of the well. One haemagglutinin unit was defined as the minimum amount of virus that agglutinated erythrocytes under the assay conditions described above.
Receptor-binding assay of HA. Recombinant HA, treated or not with ClO 2 as described above, was diluted with PBS to a concentration of 20 mg ml 21 . One hundred microlitres of this solution was then placed in each well of a 96-well, flat-bottomed polystyrene microtitre plate (MaxiSorp; Nunc) at 25 uC for 30 min. Each well of the plate was washed three times with 100 ml PBS containing 0.01 % (v/v) Tween 20 and once with 100 ml distilled water. Equine skeletal muscle myoglobin (Sigma-Aldrich) solution in PBS (1 mg ml
) was placed in each well (100 ml per well) at 25 uC for 5 min to block the protein-uncoated area of the well. The wells were washed as described above, air dried and stored at room temperature, protected from light, until use. For the receptor-binding assay, 100 ml sialyl-albumin (1.5 mg ml 21 ), as a model of truncated HA receptor, was placed in each well at 25 uC for 5 min. The wells were then washed as described above, and 100 ml HRP-labelled antihuman serum albumin antibody (diluted to 0.8 mg ml 21 ) was placed in each well at 25 uC for 5 min. The wells were then washed as described above before finally adding peroxidase substrate solution (Bio-Rad). The reaction was allowed to continue at 37 uC for 10 min before quenching by the addition of 20 mM HCl (100 ml per well). The plate was scanned using a microplate reader (model MPR-A4; Toyosoda) to measure the absorbance at 415 nm. The ability of the 96-well plate to bind HA was measured in a separate experiment. Here, after the binding, washing and drying steps as described above, 100 ml HRP-labelled anti-influenza A virus (H1N1) HA antibody (diluted to 0.5 mg ml 21 ) was placed in each well. The colourdeveloping reaction was performed as described above to quantify the amount of HA bound to each well of the plate.
HPLC of peptides. Peptides (5-20 nmol in 100 ml) were resolved on a Cosmosil 5C18-AR-300 column (4.66250 mm; Nacalai Tesque) mounted on an HPLC system. After injection of a peptide sample, the column was eluted with 0.1 % (v/v) trifluoroacetic acid containing two consecutive linear gradients of acetonitrile (0-12 %, v/v, from 0 to 1 min, and then 12-60 % , v/v, from 1 to 60 min) using a flow rate of 1 ml min
21 . An elution profile of the peptides was obtained by monitoring the absorbance of the eluate at 230 or 280 nm. Fractions of the eluate were lyophilized and dissolved in distilled water for further analysis.
MS of peptides. Peptide samples (10-500 pmol) were subjected to either MALDI-TOF MS to measure their intact mass, which is actually the m/z ratio (Biemann, 1988) , or MS/MS, after electron spray ionization of precursor ions, to analyse the amino acid sequences of the peptides, as described previously (Ogata, 2007) .
Amino acid analysis of peptides. The amino acid composition of the peptides (~200 pmol) was analysed using an amino acid analyser (model L-8500; Hitachi) after acid hydrolysis (in 6 M HCl at 110 uC for 22 h) under reduced pressure and in the presence of nitrogen. Thioglycolic acid (4 %, v/v) was added to the HCl to prevent decomposition of tryptophan during hydrolysis.
